CRISPR-HOLMES-based NAD+ detection

Songkuan Zhuang,Tianshuai Hu,Hongzhong Zhou,Shiping He,Jie Li,Yuehui Zhang,Dayong Gu,Yong Xu,Yijian Chen,Jin Wang

DOI: https://doi.org/10.3389/fbioe.2024.1355640

IF: 5.7

2024-03-26

Frontiers in Bioengineering and Biotechnology

Abstract:Studies have indicated that the intracellular nicotinamide adenine dinucleotide (NAD + ) level is associated with the occurrence and development of many diseases. However, traditional nicotinamide adenine dinucleotide (NAD + ) detection techniques are time-consuming and may require large and expensive instruments. We recently found that the clustered regularly interspaced short palindromic repeat (CRISPR)-Cas12a protein can be inactivated by AcrVA5-mediated acetylation and reactivated by CobB, using NAD + as the co-factor. Therefore, in this study, we created a CRISPR-Cas12a-based one-step HOLMES(NAD + ) system for rapid and convenient NAD + detection with the employment of both acetylated Cas12a and CobB. In HOLMES(NAD + ), acetylated Cas12a loses its trans -cleavage activities and can be reactivated by CobB in the presence of NAD + , cutting ssDNA reporters to generate fluorescence signals. HOLMES(NAD + ) shows both sensitivity and specificity in NAD + detection and can be used for quantitative determination of intracellular NAD + concentrations. Therefore, HOLMES(NAD + ) not only provides a convenient and rapid approach for target NAD + quantitation but also expands the application scenarios of HOLMES to non-nucleic acid detection.

multidisciplinary sciences